Lupin inks licensing pact with Alvion Pharmaceuticals to market drugs in Southeast Asia

Lupin inks licensing pact with Alvion Pharmaceuticals to market drugs in Southeast Asia

AgenciesUpdated: Tuesday, April 05, 2022, 05:32 PM IST
article-image
Both companies have a solid track record of developing and launching products and this agreement will further cement Lupin as a formidable pharmaceutical company in the region. / Representative Image |

Drug maker Lupin on Tuesday said it has inked a licensing pact with Alvion Pharmaceuticals to commercialise medicines for cardiometabolic diseases in Southeast Asia.

The Mumbai-based company said it is committed to providing affordable treatment options to healthcare providers and patients.

By commercialising cardiometabolic drugs in Southeast Asia, Lupin will play a significant role in improving the quality of healthcare and access to medicines, it added.

''Forming a long-term collaboration with Alvion to launch a range of therapies will allow Lupin to expand its footprint across Southeast Asia with quality cost effective alternatives for patients and the healthcare system,'' Lupin Regional Head Southeast Asia Gabriel Georgy said in a statement.

Both companies have a solid track record of developing and launching products and this agreement will further cement Lupin as a formidable pharmaceutical company in the region, he added.

''Being a leader in value-added medicines, Alvion shall support Lupin's activities aiming to position both companies at the forefront for both molecules,'' Alvion CEO John Bouros said.

(With inputs from PTI)

RECENT STORIES

India’s wealthy Class Is Shifting To UPI, Credit Cards Losing Their Shine — What’s Behind This...

India’s wealthy Class Is Shifting To UPI, Credit Cards Losing Their Shine — What’s Behind This...

Income Tax Department Imposes Two Fines Worth ₹23.07 Crore On Adani Cement Entity

Income Tax Department Imposes Two Fines Worth ₹23.07 Crore On Adani Cement Entity

IPO: Facility Management Services Provider, BVG India Files Papers With SEBI To Raise Funds From...

IPO: Facility Management Services Provider, BVG India Files Papers With SEBI To Raise Funds From...

Bihar Chief Minister Nitish Kumar Transfers ₹10,000 To 25 Lakh Women Beneficiaries Under...

Bihar Chief Minister Nitish Kumar Transfers ₹10,000 To 25 Lakh Women Beneficiaries Under...

PM Kisan 21st Installment Before Diwali, But All Farmers Will Not Get ₹2000 – Here's Why

PM Kisan 21st Installment Before Diwali, But All Farmers Will Not Get ₹2000 – Here's Why